MEDLINE Journals

    Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.

    Authors
    Bjelakovic G, Nikolova D, Gluud LL, et al. 
    Institution

    The Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Center for Clinical Intervention Research, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. goranb@junis.ni.ac.yu

    Source
    JAMA 2007 Feb 28; 297(8) :842-57.
    Abstract

    Antioxidant supplements are used for prevention of several diseases.To assess the effect of antioxidant supplements on mortality in randomized primary and secondary prevention trials. DATA SOURCES AND TRIAL SELECTION: We searched electronic databases and bibliographies published by October 2005. All randomized trials involving adults comparing beta carotene, vitamin A, vitamin C (ascorbic acid), vitamin E, and selenium either singly or combined vs placebo or vs no intervention were included in our analysis. Randomization, blinding, and follow-up were considered markers of bias in the included trials. The effect of antioxidant supplements on all-cause mortality was analyzed with random-effects meta-analyses and reported as relative risk (RR) with 95% confidence intervals (CIs). Meta-regression was used to assess the effect of covariates across the trials.We included 68 randomized trials with 232 606 participants (385 publications).When all low- and high-bias risk trials of antioxidant supplements were pooled together there was no significant effect on mortality (RR, 1.02; 95% CI, 0.98-1.06). Multivariate meta-regression analyses showed that low-bias risk trials (RR, 1.16; 95% CI, 1.04[corrected]-1.29) and selenium (RR, 0.998; 95% CI, 0.997-0.9995) were significantly associated with mortality. In 47 low-bias trials with 180 938 participants, the antioxidant supplements significantly increased mortality (RR, 1.05; 95% CI, 1.02-1.08). In low-bias risk trials, after exclusion of selenium trials, beta carotene (RR, 1.07; 95% CI, 1.02-1.11), vitamin A (RR, 1.16; 95% CI, 1.10-1.24), and vitamin E (RR, 1.04; 95% CI, 1.01-1.07), singly or combined, significantly increased mortality. Vitamin C and selenium had no significant effect on mortality.Treatment with beta carotene, vitamin A, and vitamin E may increase mortality. The potential roles of vitamin C and selenium on mortality need further study.

    Mesh
    Adult
    Antioxidants
    Ascorbic Acid
    Dietary Supplements
    Humans
    Randomized Controlled Trials as Topic
    Selenium
    Vitamin A
    Vitamin E
    beta Carotene
    Language

    eng

    Pub Type(s)
    Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review
    PubMed ID

    17327526

    Content Manager
    Related Content

    Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

    Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

    Antioxidant supplements for preventing gastrointestinal cancers.

    Systematic review: primary and secondary prevention of gastrointestinal cancers with antioxidant supplements.

    Antioxidant supplements for preventing gastrointestinal cancers.

    Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis.

    Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials.

    Meta-analysis: antioxidant supplements for liver diseases - the Cochrane Hepato-Biliary Group.